Clinical Trial Update: Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Trelstar (triptorelin) versus Lupron (leuprolide) or Zoladex (goserelin) in advanced prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lupron (leuprolide)
• TRELSTAR (Triporelin pamoate)
• Zoladex (goserelin)

Snippet

Sponsor: Pharmatech | Conditions: Prostate Cancer | Phase 4 | Status: TERMINATED